Influence of the in situ component in 389 infiltrating ductal breast carcinomas

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Breast Cancer

• Publication date

  2013-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s12282-011-0330-1PMID 22271067
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Computerized classification of intraductal breast lesions using histopathological images

  2011cited by this paper
• Ductal carcinoma in situ: terminology, classification, and natural history.

  2010cited by this paper
• The molecular journey from ductal carcinoma in situ to invasive breast cancer

  2008cited by this paper
• Biology and treatment of ductal carcinoma in situ

  2007cited by this paper
• Distinct epigenetic changes in the stromal cells of breast cancers

  2005cited by this paper
• Molecular characterization of the tumor microenvironment in breast cancer.

  2004cited by this paper
• Patterns of Chromosomal Alterations in Breast Ductal Carcinoma In situ

  2004cited by this paper
• Molecular markers in ductal carcinoma in situ of the breast.

  2003cited by this paper
• Expert Commentary.

  2002cited by this paper
• Ductal invasive G2 and G3 carcinomas of the breast are the end stages of at least two different lines of genetic evolution

  2001cited by this paper
• Biological Features of Premalignant Disease in the Human Breast

  2000cited by this paper
• Analysis of loss of heterozygosity in 399 premalignant breast lesions at 15 genetic loci.

  1998cited by this paper
• Analysis of loss of heterozygosity on chromosome 11q13 in atypical ductal hyperplasia and in situ carcinoma of the breast.

  1997cited by this paper
• Prognostic classification of breast ductal carcinoma-in-situ.

  1995cited by this paper
• Distribution of estrogen receptor in ductal carcinoma in situ of the breast.

  1993cited by this paper
• Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer.

  1993cited by this paper
• pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐up

  1991cited by this paper
• Nuclear and flow cytometric characteristics associated with overexpression of the c-erbB-2 oncoprotein in breast carcinoma

  1991cited by this paper
• Correlation of DNA ploidy with c-erbB-2 expression in preinvasive and invasive breast tumors.

  1991cited by this paper
• Immunohistochemical evaluation of c-erbB-2 oncogene expression in ductal carcinoma in situ and atypical ductal hyperplasia of the breast.

  1990cited by this paper
• Estrogen receptors in ductal carcinoma in situ of breast.

  1990cited by this paper
• Potential value of hormone receptor assay in carcinoma in situ of breast.

  1990cited by this paper
• In situ carcinoma of the breast.

  1989cited by this paper
• Diagnostic Histopathology of the Breast

  1988cited by this paper
• Risk factors for breast cancer in women with proliferative breast disease.

  1985cited by this paper
• 喉頭の Epithelial Hyperplasia

  1980cited by this paper

• The impact of extensive intraductal component (EIC) on the genomic risk of recurrence in early hormone receptor positive breast cancer

  2024cites this paper
• Prognostic Implications of Concurrent Ductal Carcinoma In Situ in Invasive Breast Cancer: an Observational Nested Cohort Study from a Regional Cancer Center in India

  2023influential citation
• Clinicopathological characteristics and prognosis of triple-negative breast cancer invasive ductal carcinoma with ductal carcinoma in situ.

  2023cites this paper
• Isogenic Mammary Models of Intraductal Carcinoma Reveal Progression to Invasiveness in the Absence of a Non-Obligatory In Situ Stage

  2023cites this paper
• A comparative clinicopathological and survival analysis of synchronous bilateral breast cancers.

  2022cites this paper
• Does Existence of Ductal Carcinoma In Situ Accompanying Invasive Ductal Carcinoma Lead to Different Clinicopathological Features and Clinical Outcome? Report of a Breast Cancer Registry

  2022cites this paper
• Extensive Intraductal Component in Breast Cancer: What Role in Disease-Free Survival?

  2022cites this paper
• Breast cancer vaccines: New insights into immunomodulatory and nano-therapeutic approaches.

  2022cites this paper
• Does concomitant ductal carcinoma in situ affect the clinical outcome in breast cancer patients with invasive ductal carcinoma: An Asian perspective

  2022cites this paper
• Thyroid Hormones and Morphological Features of Primary Breast Cancer

  2021cites this paper
• Does Concomitant DCIS Affect the Clinical Outcome in Breast Cancer Patients with Invasive Ductal Carcinoma: an Asian Perspective

  2020cites this paper
• Comparison of clinicopathological characteristics and prognosis among patients with pure invasive ductal carcinoma, invasive ductal carcinoma coexisted with invasive micropapillary carcinoma, and invasive ductal carcinoma coexisted with ductal carcinoma in situ

  2020cites this paper
• The prognostic significance of co-existence ductal carcinoma in situ in invasive ductal breast cancer: a large population-based study and a matched case-control analysis.

  2019cites this paper
• Overall survival is improved when DCIS accompanies invasive breast cancer

  2019cites this paper
• Influence of ductal carcinoma in situ on the outcome of invasive breast cancer. A prospective cohort study.

  2019cites this paper
• The association between mammographic calcifications and breast cancer prognostic factors in a population‐based registry cohort

  2017cites this paper
• Histogram analysis of volume-based apparent diffusion coefficient in breast cancer

  2017cites this paper
• Breast cancer risk factor associations differ for pure versus invasive carcinoma with an in situ component in case–control and case–case analyses

  2015cites this paper
• Grade of ductal carcinoma in situ accompanying infiltrating ductal carcinoma as an independent prognostic factor.

  2013cites this paper